Possible clinical usefulness of polygenic risk scores among patients with established atherosclerotic cardiovascular disease

Atherosclerosis. 2022 Jun:350:100-101. doi: 10.1016/j.atherosclerosis.2022.04.024. Epub 2022 Apr 28.

Authors

Kouichi Tamura¹, Tomohiro Kumagai², Kazuo Kobayashi²

Affiliations

¹ Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Electronic address: tamukou@med.yokohama-cu.ac.jp.
² Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

PMID: 35508429
DOI: 10.1016/j.atherosclerosis.2022.04.024

No abstract available

Keywords: Clinical risk assessment and management; Genome; Hypertension; Low-density lipoprotein; Risk algorithm.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Atherosclerosis* / diagnosis
Atherosclerosis* / genetics
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / genetics
Humans
Hyperlipoproteinemia Type II*
Risk Factors